NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-192-1999-0-AU-03 Determination of an Empirical Statistical Distribution of the Diffusion Tensor in MRI AU National Stage 51603/00 Abandoned
NCI E-070-2000-0-PCT-01 INHIBITION OF SMAD3 TO PREVENT FIBROSIS AND TO IMPROVE WOUND HEALING PCT PCT PCT/US00/13725 Abandoned
CC E-013-1999-0-PCT-02 Magnetic Resonance Tracking of Magnetically Labeled Cells PCT PCT PCT/US00/13826 Expired
NICHD E-192-1999-0-PCT-02 Determination of an Empirical Statistical distribution of The Diffusion Tensor in MRI PCT PCT PCT/US00/014290 Expired
NCI E-070-2000-0-JP-05 INHIBITION OF SMAD3 TO PREVENT FIBROSIS AND TO IMPROVE WOUND HEALING JP National Stage 2001-585799 Abandoned
NCI E-070-2000-0-EP-04 INHIBITION OF SMAD3 TO PREVENT FIBROSIS AND TO IMPROVE WOUND HEALING EP National Stage 00932586.1 Abandoned
NICHD E-192-1999-0-EP-05 System for Analyzing Diffusion Tensor Magnetic Resonance Images EP National Stage 00936262.5 Abandoned
NHLBI E-265-2000-0-US-01 Murine Interleukin Receptor (mILR) US ORD 09/574,535 Abandoned
NCI E-131-2000-0-US-01 Methods For Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity US 60/205,757 Abandoned
NCI E-134-2000-0-US-01 Utilization of Non-Viral Sequences For Minus-Strand DNA Transfer and Gene Reconstitution US 60/205,395 Abandoned
NCI E-070-2000-0-CA-03 INHIBITION OF SMAD3 TO PREVENT FIBROSIS AND TO IMPROVE WOUND HEALING CA National Stage 2410987 Abandoned
NICHD E-027-1999-0-PCT-02 Materials and Methods for Enzymatic N-Acetylation of Arylalkylamines PCT PCT PCT/US00/13656 Abandoned
NIMH E-044-1997-1-US-01 Immunotoxin Fusion Proteins and Means For Expression Thereof US CIP 09/573,797 Abandoned
NCI E-219-1995-0-US-03 Antibodies to the Protein Product Encoded by ORF3 of the TRP-1 Gene and Compositions and Kits Thereof US DIV 09/571,313 7015312 Abandoned PDF
NCI E-010-1999-0-JP-09 TREATMENT OF KAPOSI'S SARCOMA WITH IL-12 JP ORD 2002-569833 Abandoned
NIMH E-088-1998-0-PCT-02 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium PCT PCT PCT/US00/06718 Expired
NCI E-058-1998-0-US-04 Pseudomonas Exotoxin A-Like Chimeric Immunogens For Eliciting A Secretory IGA-Mediated Immune Response US National Stage 09/462,713 Abandoned
NIMH E-088-1998-0-JP-09 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium JP National Stage 2000-617737 Abandoned
NIMH E-088-1998-0-EP-06 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium EP National Stage 00931911.2 Abandoned
NIMH E-088-1998-0-CA-05 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium CA National Stage 2373486 Abandoned
NIMH E-088-1998-0-AU-04 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium AU National Stage 49719/00 Abandoned
NIDDK E-104-1989-0-US-12 BIOLOGICALLY ACTIVE SYNTHETIC THYROTROPIN AND CLONED GENE FOR PRODUCING SAME US FWC 09/569,141 6284491 Expired PDF
NIDDK E-165-1999-0-US-01 Potentiation of Antineoplastic Agents Using Sigma-2 Ligands US 60/203,220 Abandoned
NCI E-036-1999-0-EP-06 Thiazepine Inhibitors of HIV-1 Integrase EP National Stage 00932279.3 Abandoned
NCI E-036-1999-0-IE-08 Thiazepine Inhibitors of HIV-1 Integrase IE EP 00932279.3 Abandoned
NCI E-036-1999-0-GB-07 Thiazepine Inhibitors of HIV-1 Integrase GB EP 00932279.3 Abandoned
NCI E-151-2007-2-AU-03 Nucleotide Sequences Of HIV-1 Type (or Subtype) O Retrovirus Antigens AU DIV 34000/00 Expired
NCI E-036-1999-0-AU-04 Thiazepine Inhibitors of HIV-1 Integrase AU National Stage 50021/00 Abandoned
NCI E-075-2000-0-US-01 NITRIC OXIDE Releasing Metallic Medical Devices US ORD 09/567,579 6270779 Expired PDF
NCI E-036-1999-0-PCT-02 Thiazepine Inhibitors of HIV-1 Integrase PCT PCT PCT/US00/12847 Abandoned
NCI E-036-1999-0-CA-05 Thiazepine Inhibitors of HIV-1 Integrase CA National Stage 2372791 Abandoned
NIAID E-161-1997-0-US-03 Methods For Inactivating Enveloped RNA Virus Particles and Compositions For Use Therein US National Stage 09/446,959 6426070 Abandoned PDF
NIBIB E-015-1999-0-PCT-02 Surface Coatings for Hot-Melt Adhesive Films PCT PCT PCT/US00/012604 Expired
NIDDK E-323-2002-0-EP-04 USE OF A3 ADENOSINE RECEPTOR ANTAGONISTS IN THE MANUFACTURE OF A MEDICAMENT FOR REDUCING INTRAOCULAR PRESSURE EP National Stage 99935665.2 Expired
NIDDK E-323-2002-0-PCT-02 Methods for Controlling Intraocular Pressure PCT PCT PCT/US2000/012551 Expired
NIDDK E-323-2002-0-GB-05 USE OF A3 ADENOSINE RECEPTOR ANTAGONISTS IN THE MANUFACTURE OF A MEDICAMENT FOR REDUCING INTRAOCULAR PRESSURE GB EP 99935665.2 Expired
NCI E-181-1999-0-EP-04 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector EP National Stage 00939374.5 Expired
NCI E-271-1998-0-EP-05 Methods for Treating Tumors Using Antiangiogenic Compounds EP National Stage 00930428.8 Abandoned
NCI E-271-1998-0-GB-10 Methods for Treating Tumors Using Antiangiogenic Compounds GB EP 00930428.8 Abandoned
NCI E-271-1998-0-FR-08 Methods for Treating Tumors Using Antiangiogenic Compounds FR EP 00930428.8 Abandoned
NCI E-271-1998-0-DE-09 Methods for Treating Tumors Using Antiangiogenic Compounds DE EP 00930428.8 Abandoned
NCI E-271-1998-0-AU-03 Methods for Treating Tumors Using Antiangiogenic Compounds AU National Stage 48249/00 Abandoned
NCI E-164-1999-0-PCT-02 T20/D178 And T21/D107 Are Activators of Human Phagocyte Formyl Peptide Receptors PCT PCT PCT/US2000/012371 Expired
NCI E-271-1998-0-PCT-02 Methods for Treating Tumors Using Antiangiogenic Compounds PCT PCT PCT/US00/12392 Abandoned
NIAID E-221-2000-2-PCT-01 Live Attenuated Newcastle Disease Vaccine PCT PCT COMB PCT/US2000/006700 Expired
NCI E-271-1998-0-JP-06 Methods for Treating Tumors Using Antiangiogenic Compounds JP National Stage 2000-616345 Abandoned
NCI E-271-1998-0-CA-04 Methods for Treating Tumors Using Antiangiogenic Compounds CA National Stage 2372699 Abandoned
NIDDK E-032-1999-0-PCT-02 DIRECT C-14 OXIDATION OF OPIOIDS PCT PCT PCT/US00/12357 Abandoned
NIAAA E-041-2000-0-US-01 METHODS FOR INHIBITING CALPAIN US 60/202,378 Abandoned
NIAID E-050-1997-0-US-03 METHOD OF SAMPLING, AMPLIFYING AND QUANTIFYING SEGMENT OF NUCLEIC ACID,
POLYMERASE CHAIN REACTION ASSEMBLY HAVING NANOLITER-SIZED SAMPLE CHAMBERS,
AND METHOD OF FILLING ASSEMBLY 		US DIV 09/563,714 6391559 Expired PDF